Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 236

    Dr Reddys Labs gets EIR from USFDA for Srikakulam unit

    Dr Reddy's Labs gets EIR from USFDA for Srikakulam unit

    Ruby Khatun Khatun24 Aug 2018 10:30 AM IST
    New Delhi: Dr Reddy's Laboratories said it has received an Establishment Inspection Report (EIR) from the US health regulator for its Srikakulam...
    Lupin recalls over 11,000 bottles of hypertension drug in US

    Lupin recalls over 11,000 bottles of hypertension drug in US

    Medical Dialogues Bureau24 Aug 2018 10:15 AM IST
    New Delhi: Lupin's US arm is recalling 11,706 bottles of Lisinopril tablets, used for treating hypertension, from the American market, USFDA said.The...
    Ayushman Bharat scheme credit positive for insurers: Moodys

    Ayushman Bharat scheme credit positive for insurers: Moody's

    Ruby Khatun Khatun24 Aug 2018 10:00 AM IST
    Mumbai: The government's flagship health insurance scheme, Ayushman Bharat, is credit positive for insurance companies as it will aide in higher...
    FDA declines to approve Allergan

    FDA declines to approve Allergan's Esmya

    Medical Dialogues Bureau24 Aug 2018 9:45 AM IST
    Allergan Plc said U.S. health regulators had declined to approve Esmya, its treatment for abnormal uterine bleeding in women with uterine fibroids,...
    GSK seeks bids for 4 billion dollar India sale by mid-Sept: Report

    GSK seeks bids for 4 billion dollar India sale by mid-Sept: Report

    Medical Dialogues Bureau24 Aug 2018 9:30 AM IST
    UK pharmaceutical giant GSK has requested bids by mid-September for its $4.3-billion Indian consumer-health unit, which owns the popular malted milk...
    Lupin launches Clobetasol Propionate Skin cream in US

    Lupin launches Clobetasol Propionate Skin cream in US

    Garima23 Aug 2018 1:18 PM IST
    Clobetasol Propionate cream is "indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatosesNew Delhi:...
    Pfizer, Astellas to Change Xtandis Trial Protocols to Speed Up Results

    Pfizer, Astellas to Change Xtandi's Trial Protocols to Speed Up Results

    Garima23 Aug 2018 10:00 AM IST
    New Delhi: Drugmakers Pfizer Inc and Astellas Pharma Inc recently stated that they would change protocols for two late-stage trials testing prostate...
    Lupin gets USFDA approval for Mild Atopic dermatitis treatment lotion

    Lupin gets USFDA approval for Mild Atopic dermatitis treatment lotion

    Garima23 Aug 2018 9:30 AM IST
    New Delhi: Drug major Lupin recently stated it has received final approval from the United States Food and Drug Administration (USFDA) to market...
    Wasazra plans to Expand PAN India

    Wasazra plans to Expand PAN India

    Garima23 Aug 2018 9:00 AM IST
    Lucknow: Last year has gone extremely well for Wasazra, in just one year, the company registered as public limited and has been instrumental in...
    Strides receives acceptance from USFDA for two ANDAs

    Strides receives acceptance from USFDA for two ANDAs

    Medical Dialogues Bureau22 Aug 2018 7:06 PM IST
    New Delhi: Strides Pharma Science today said its step-down wholly owned subsidiary has received acceptance from the US health regulator for two key...
    Medtronic reports about 6 pct rise in quarterly profit

    Medtronic reports about 6 pct rise in quarterly profit

    Medical Dialogues Bureau22 Aug 2018 7:06 PM IST
    Medical device maker Medtronic plc reported a near 6 per cent rise in quarterly profit on Tuesday, helped by higher sales in its cardiac and vascular...
    Continental Hospitals launches I am Emergency Ready training drive in Hyderabad

    Continental Hospitals launches I am Emergency Ready training drive in Hyderabad

    Ruby Khatun Khatun22 Aug 2018 10:30 AM IST
    New Delhi: Continental Hospitals launched the 'I am Emergency Ready' emergency drive to raise awareness on emergency preparedness amongst the common...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    CDSCO updates procedure for issuance of WHO GMP

    CDSCO updates procedure for issuance of WHO GMP

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok